Cyclacel Pharmaceuticals, Inc. - Rasio nilai perusahaan marang dodolan CYCC

Simbol resmi perusahaan cyclacel.com (CYCC)

The success of Cyclacel Pharmaceuticals (CYCC) relies on the efficacy of CDK inhibitors in treating leukemias and the absence of side effects. The enterprise value-to-revenue ratio demonstrates multiplier dynamics, where the value represents the current metric. While data on fadraziclib and a precision approach to mutations drive growth, the lack of sales leaves the capitalization dependent on trial results.

Cyclacel, Inc. (CYCC): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Cyclacel Pharmaceuticals Inc. - rincian analitis lan metrik utama (CYCC)

Pambiji fundamental perusahaan:CYCC, cyclacel.com
Produk sing diprodhuksi Cyclacel Pharmaceuticals, Inc.

This indicator measures the enterprise value minus net debt relative to sales volume, allowing for the determination of the asset's premium regardless of its financial leverage. By analyzing the company's valuation based on revenue excluding debt on GURU.Markets, an investor can assess the extent to which the capitalization of Cyclacel Pharmaceuticals (CYCC) is justified by its intellectual patents amidst costly clinical trials for cancer drugs.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|CMRX: Nilai bisnis marang pendapatan|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales